RXi Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch RXII and buy or sell other stocks, ETFs, and their options commission-free!About RXII
SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S.
CEOAngelos M. Stergiou, MD
CEOAngelos M. Stergiou, MD
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2006
Founded2006
Employees—
Employees—
RXII Key Statistics
Market cap290.58M
Market cap290.58M
Price-Earnings ratio-7.11
Price-Earnings ratio-7.11
Dividend yield—
Dividend yield—
Average volume6.09M
Average volume6.09M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.48
52 Week high$2.48
52 Week low$0.8335
52 Week low$0.8335
Stock Snapshot
As of today, RXi Pharmaceuticals(RXII) shares are valued at $2.32. The company's market cap stands at 290.58M, with a P/E ratio of -7.11.
RXi Pharmaceuticals(RXII) stock opened on 2025-12-15 at —. The price climbed to — and dipped to —.
RXi Pharmaceuticals(RXII) shares are trading with a volume of 0, against a daily average of 6.09M.
In the last year, RXi Pharmaceuticals(RXII) shares hit a 52-week high of $2.48 and a 52-week low of $0.83.
In the last year, RXi Pharmaceuticals(RXII) shares hit a 52-week high of $2.48 and a 52-week low of $0.83.